Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FBXO45-MYCBP2 regulates mitotic cell fate by targeting FBXW7 for degradation
Kai T. Richter, Yvonne T. Kschonsak, Barbara Vodicska, et al.
Cell Death and Differentiation (2019) Vol. 27, Iss. 2, pp. 758-772
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Clinical significance of FBXW7 loss of function in human cancers
Jingyi Fan, Marcia Bellon, Mingyi Ju, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 88
Comparative Multiplexed Interactomics of SARS-CoV-2 and Homologous Coronavirus Nonstructural Proteins Identifies Unique and Shared Host-Cell Dependencies
Jonathan P. Davies, Katherine M. Almasy, Eli Fritz McDonald, et al.
ACS Infectious Diseases (2020) Vol. 6, Iss. 12, pp. 3174-3189
Open Access | Times Cited: 118
A new dawn beyond lysine ubiquitination
Daniel R. Squair, Satpal Virdee
Nature Chemical Biology (2022) Vol. 18, Iss. 8, pp. 802-811
Closed Access | Times Cited: 60
Structural basis for RING-Cys-Relay E3 ligase activity and its role in axon integrity
Peter D. Mabbitt, Andrea Loreto, Marc-André Déry, et al.
Nature Chemical Biology (2020) Vol. 16, Iss. 11, pp. 1227-1236
Open Access | Times Cited: 56
Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation
Xiaotong Lin, Hongqiang Yu, Lei Fang, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 54
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
Linhui Wu, Ke Yu, Kai Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 38
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Siyu Chen, Ping Leng, Jinlin Guo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 17
FBXW7 tumor suppressor regulation by dualspecificity tyrosine-regulated kinase 2
Rafael Jiménez‐Izquierdo, Rosario Morrugares, Lucía Suanes-Cobos, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 3
Open Access | Times Cited: 16
Ubiquitination and deubiquitination in the regulation of N6-methyladenosine functional molecules
Yue Zhao, Jiaojiao Huang, Kexin Zhao, et al.
Journal of Molecular Medicine (2024) Vol. 102, Iss. 3, pp. 337-351
Closed Access | Times Cited: 5
Ginsenoside Rg1 Regulates Immune Microenvironment and Neurological Recovery After Spinal Cord Injury Through MYCBP2 Delivery via Neuronal Cell‐Derived Extracellular Vesicles
Yuluo Rong, Jiaxing Wang, Tao Hu, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 5
FBXO45 is a potential therapeutic target for cancer therapy
Min Lin, Zhiwei Wang, Xueqiong Zhu
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 32
Comparative multiplexed interactomics of SARS-CoV-2 and homologous coronavirus non-structural proteins identifies unique and shared host-cell dependencies
Jonathan P. Davies, Katherine M. Almasy, Eli Fritz McDonald, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 29
Fbxo45 promotes the malignant development of esophageal squamous cell carcinoma by targeting GGNBP2 for ubiquitination and degradation
Qi Wang, Linhui Wu, Ruoxue Cao, et al.
Oncogene (2022) Vol. 41, Iss. 43, pp. 4795-4807
Closed Access | Times Cited: 18
An atypical ubiquitin ligase at the heart of neural development and programmed axon degeneration
Satpal Virdee
Neural Regeneration Research (2022) Vol. 17, Iss. 11, pp. 2347-2347
Open Access | Times Cited: 17
SCF FBXW5 -mediated degradation of AQP3 suppresses autophagic cell death through the PDPK1-AKT-MTOR axis in hepatocellular carcinoma cells
Yupei Liang, Ping Chen, Shiwen Wang, et al.
Autophagy (2024) Vol. 20, Iss. 9, pp. 1984-1999
Closed Access | Times Cited: 3
A Perspective on Therapeutic Targeting Against Ubiquitin Ligases to Stabilize Tumor Suppressor Proteins
Ishaar P. Ganesan, Hiroaki Kiyokawa
Cancers (2025) Vol. 17, Iss. 4, pp. 626-626
Open Access
CACNA1C-AS2 inhibits cell proliferation and suppresses cell migration and invasion via targeting FBXO45 and PI3K/AKT/mTOR pathways in glioma
Tong Cao, Yue Cui, Yingying Wang, et al.
APOPTOSIS (2022) Vol. 27, Iss. 11-12, pp. 979-991
Closed Access | Times Cited: 13
Anticancer function of microRNA‐30e is mediated by negative regulation of HELLPAR, a noncoding macroRNA, and genes involved in ubiquitination and cell cycle progression in prostate cancer
Kavya Ganapathy, Christopher Ngo, Thomas Andl, et al.
Molecular Oncology (2022) Vol. 16, Iss. 16, pp. 2936-2958
Open Access | Times Cited: 12
The SCF–FBXW7 E3 ubiquitin ligase triggers degradation of histone 3 lysine 4 methyltransferase complex component WDR5 to prevent mitotic slippage
Simon Hänle-Kreidler, Kai T. Richter, Ingrid Hoffmann
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102703-102703
Open Access | Times Cited: 12
Annexin A1 binds PDZ and LIM domain 7 to inhibit adipogenesis and prevent obesity
Lu Fang, Changjie Liu, Zongzhe Jiang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 2
HDAC7 drives glioblastoma to a mesenchymal-like state via LGALS3-mediated crosstalk between cancer cells and macrophages
Shulin Zhao, Rongrong Zhao, Chuanzheng Wang, et al.
Theranostics (2024) Vol. 14, Iss. 18, pp. 7072-7087
Open Access | Times Cited: 2
Comparing cell‐free circulating tumorDNAmutational profiles of disease‐free and nonresponders patients with oropharyngeal squamous cell carcinoma
Alok R. Khandelwal, Adam H. Greer, Mickie Hamiter, et al.
Laryngoscope Investigative Otolaryngology (2020) Vol. 5, Iss. 5, pp. 868-878
Open Access | Times Cited: 15
Function, mechanism and drug discovery of ubiquitin and ubiquitin-like modification with multiomics profiling for cancer therapy
Yanyu Jiang, Shuaishuai Ni, Biying Xiao, et al.
Acta Pharmaceutica Sinica B (2023) Vol. 13, Iss. 11, pp. 4341-4372
Open Access | Times Cited: 5
Targeting Post-Translational Modifications of the p73 Protein: A Promising Therapeutic Strategy for Tumors
Ziad Omran, Mahmood Hassan Dalhat, Omeima Abdullah, et al.
Cancers (2021) Vol. 13, Iss. 8, pp. 1916-1916
Open Access | Times Cited: 11
FBXO9 Mediates the Cancer-Promoting Effects of ZNF143 by Degrading FBXW7 and Facilitates Drug Resistance in Hepatocellular Carcinoma
Zhenyu Wang, Xiaoxia Chen, Lianer Zhou, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top